Our Practice Advisory for Physician Workflow
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help doctors make better choices when ordering certain lab tests, specifically Hemoglobin A1c (used to monitor blood sugar) and Thyroid-Stimulating Hormone (TSH) tests. The goal is to reduce unnecessary repeat tests within 30 days, which often do not provide new information. By providing doctors with reminders through their electronic health records using the Practice Advisory (OPA), the study seeks to improve test utilization and enhance patient care. The trial is ideal for patients at UCLA Health who have had recent A1c or TSH tests in the last month. As an unphased trial, it offers patients the opportunity to contribute to optimizing healthcare practices and improving patient care.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on testing practices rather than medication use.
What prior data suggests that this protocol is safe for provider decision-making?
Research shows that the Our Practice Advisory (OPA) helps doctors make better decisions when ordering tests like Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH). Although specific safety data for OPA is unavailable, it is important to note that it is not a drug or medical procedure. Instead, it supports decision-making and does not directly affect the body, so there are no typical side effects or safety concerns like those associated with medications.
OPA aims to reduce unnecessary repeat testing, saving time and resources without compromising the quality of patient care. No evidence suggests negative effects from using this advisory tool, making it safe for use in medical settings. Therefore, participating in this type of study involves little to no risk to health.12345Why are researchers excited about this trial?
Researchers are excited about the Our Practice Advisory (OPA) because it offers a new approach to reducing unnecessary medical testing. Unlike current standard practices that often lead to repeated tests, OPA provides real-time alerts through the electronic health record (EHR) system, prompting healthcare providers to reconsider ordering Hemoglobin A1c and Thyroid-Stimulating Hormone tests if they have been requested within the past 30 days. This proactive strategy aligns with evidence-based guidelines, aiming to optimize testing efficiency and enhance patient care. By minimizing redundant tests, OPA has the potential to streamline physician workflow and reduce healthcare costs, making it a promising innovation in medical practice management.
What evidence suggests that this advisory is effective for reducing unnecessary A1c and TSH testing?
Research shows that the Our Practice Advisory (OPA), which participants in this trial may receive, reduces unnecessary repeat tests by following evidence-based guidelines. Studies have found that when doctors receive these alerts, they reconsider ordering tests like Hemoglobin A1c and Thyroid-Stimulating Hormone if conducted in the past 30 days. This approach can lead to better resource use and improve patient care by avoiding repeated tests. The alerts aim to help doctors make more efficient decisions, ultimately enhancing patient outcomes without overburdening the healthcare system.678910
Are You a Good Fit for This Trial?
This trial is for healthcare providers who order Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) tests. It aims to improve their decision-making by reducing unnecessary repeat testing within a short period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Providers receive or do not receive the Our Practice Advisory (OPA) when ordering A1c and TSH tests within 30 days of prior results
Follow-up
Participants are monitored for changes in test ordering behavior and outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Our Practice Advisory (OPA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor